As researchers close in on an effective malaria vaccine, the Bill and Melinda Gates Foundation deserves credit for providing funding to a pharmaceutical company to offset the financial risks of devoting resources to an untested procedure. With preliminary tests showing significant drops in infection rates, the process stand as a testament to the powerful effect charitable giving can have on industry, The New York Times writes.

Full Story:

Related Summaries